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ABSTRACT
Background: Hypertension requires life-long medical care, which may cause economic 
burden and even lead to catastrophic health expenditure.
Objective: To estimate the extent of out-of-pocket expenditure for hypertension care at 
a population level and its impact on households’ budgets in a low-income urban setting in 
Colombia.
Methods: We conducted a cross-sectional survey in Santa Cruz, a commune in the city of 
Medellin. In 410 randomly selected households with a hypertensive adult, we estimated annual 
basic household expenditure and hypertension-attributable out-of-pocket expenditure. For 
socioeconomic stratification, we categorised households according to basic expenditure quin-
tiles. Catastrophic hypertension-attributable expenditure was defined as out-of-pocket expen-
diture above 10% of total household expenditure.
Results: The average annual basic household expenditure was US dollars at purchasing power 
parity (USD-PPP) $12,255.59. The average annual hypertension-attributable out-of-pocket 
expenditure was USD-PPP $147.75 (95% CI 120.93–174.52). It was incurred by 73.9% (95% CI 
69.4%-78.1%) of patients, and consisted mainly of direct non-medical expenses (76.7%), pre-
dominantly for dietary requirements prescribed as non-pharmacological treatment and for 
transport to attend health care consultations. Medical out-of-pocket expenditure (23.3%) was 
for the most part incurred for pharmacological treatment. Hypertension-attributable out-of- 
pocket expenditure represented on average 1.6% (95% CI 1.3%-1.9%) of the total annual basic 
household expenditure. Eight households (2.0%; 95% CI 1.0%-3.8%) had catastrophic health 
expenditure; six of them belonged to the two lowest expenditure quintiles. Payments related to 
dietary requirements and transport to consultations were critical determinants of their cata-
strophic expenditure.
Conclusions: Out-of-pocket expenditure for hypertension care is moderate on average, but 
frequent, and mainly made up of direct non-medical expenses. Catastrophic health expendi-
ture is uncommon and affects primarily households in the bottom socioeconomic quintiles. 
Financial protection should be strengthened by covering the costs of chronic diseases-related 
dietary requirements and transport to health services in the most deprived households.
Abbreviations: NCDs: Non-communicable diseases; LMICs: Low and middle-income coun-
tries; WHO: World Health Organization; HTN: hypertension; CVDs: Cardiovascular diseases; 
OOPE: out-of-pocket expenditure; USD-PPP: US dollars at purchasing power parity; CI: 
Confidence interval
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Background
Non-Communicable Diseases (NCDs) are the leading 
cause of death worldwide, accounting for an estimated 
71% of all demises in 2016 [1]. Four out of five of these 
deaths occur in low and middle-income countries 
(LMICs) [2]. United Nations high-level meetings held 
in the last decade [3–5] highlighted the impact of NCDs 
on global health and development. Recent reports from 
the World Health Organization (WHO) and other 
international agencies also emphasised the threat that 
NCDs pose to developing countries and urge to scale up 
programs and policies to address their growing burden 
[6–8].
Uncontrolled hypertension (HTN) is a key mod-
ifiable risk factor for cardiovascular diseases (CVDs), 
the major NCDs, and is associated to more than 
10 million preventable deaths each year [9]. CVDs 
mainly hit the middle-aged population in LMICs 
[10]. In Latin America and the Caribbean alone, 
1.6 million people die from CVDs every year (38% 
of all deaths), half a million of them before 70 years 
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of age [11]. In Colombia, 32% of deaths and 18% of 
Years of Life Lost in 2016 can be attributed to CVDs 
[12]. High HTN prevalence, poor control, and weak 
health systems’ response are critical factors fuelling 
the rising epidemic of CVDs and its increasing costs 
in LMICs [8,13,14].
HTN requires life-long care, but unfortunately 
management of NCDs is often reduced to the belated 
treatment of complications or acute exacerbations, in 
specialised settings, and at high cost [15,16]. Not 
surprisingly, most out-of-pocket expenditure 
(OOPE) for health care is related to NCDs [7,16]. 
Health care financing that relies on OOPE is ineffi-
cient and inequitable and creates significant access 
barriers [17,18]. Despite economic growth in the 
Americas region during the last two decades, an 
estimated 30% of the region’s population still has no 
access to care due to financial obstacles [19]. 
Furthermore, according to WHO and the World 
Bank, between 2000 and 2010 two to four million 
people in nine Latin American and Caribbean coun-
tries were driven into poverty by OOPE [20]. For the 
poor, even spending a small amount of money can 
take a substantial out portion of the household’s dis-
posable income [19].
Colombian insurance schemes do not reimburse 
health care expenses, but directly remunerate the 
provider they contract with for the ambulatory care 
delivered as part of HTN disease management pro-
grams [21,22]. However, an exploratory service-based 
study [23] suggests that Colombian families often 
have to bear HTN-related expenses, mainly for anti- 
hypertensive drugs, referrals, and transport. 
Collecting information on OOPE can make an essen-
tial contribution to policy formulation towards uni-
versal health coverage, development of equitable 
health care services, financial protection and social 
justice [20]. Notwithstanding, population-based evi-
dence on OOPE for HTN in the Americas derives 
from the high-income northern countries of the 
region only [24–26].
The main objective of the present study is to 
estimate the extent of OOPE for HTN at 
a population level in an urban Colombian setting 
and to investigate whether accessing HTN care leads 
to catastrophic health expenditure.
Methods
Study setting
The Colombian health care system has two different 
insurance schemes: the contributory and the subsi-
dised. Premium payments to the contributory scheme 
are compulsory for formally employed workers, peo-
ple receiving pensions and the self-employed with an 
income above the minimum monthly salary (689,455 
Colombian Pesos, about 209 US dollars). The State 
finances the subsidised scheme. The set-up is orga-
nised along private market mechanisms, with the role 
of the State limited to guaranteeing competition and 
ordered interaction. Health insurance companies 
contract the provision of care with health provider 
institutions -private ones or autonomous public enti-
ties- based on capitation and fee-for-service pay-
ments. Regardless of scheme, affiliates and their 
dependents are entitled to benefits comprising 
a standardised health care package. Hypertensive 
patients are exempt from paying fees for consulta-
tions, medication and laboratory examinations at 
first-line health services. Cosmetic procedures, 
experimental treatments and health services not avail-
able in the country, amongst others, are excluded 
from the benefits package, but in principle – albeit 
not in practice- all insured have also access to sec-
ondary and tertiary care.
Our study was conducted in 2016 in the 
Commune of Santa Cruz, Medellin, Colombia. 
Medellin is the second-largest industrialised city of 
Colombia. In 2016, its total population was around 
2.5 million [27]. Santa Cruz, one of its sixteen 
Communes, is located in the northeast of Medellin, 
and the second most deprived area of the city [28]. In 
2015, it had a total population of 111,452 (53% 
women and 47% men) [29]. Nearly 55% of the popu-
lation is insured under the contributory scheme, 
about 44% under the subsidised scheme and 1% 
does not have any insurance coverage [30]. We spe-
cifically chose this Commune because it is urban and 
has a predominantly low-income population, making 
it akin to the environments the majority of people in 
Latin America is currently living in. It is representa-
tive of Colombia’s national health system’s function-
ing, and the major health care provider in the area is 
committed to interventions for improving HTN con-
trol activities based on our research results.
Sampling
We used stratified cluster sampling. To estimate the 
HTN prevalence with 2% precision, allowing for an 
alpha error of 5% and assuming 1.5 adults over 
35 years per household, a prior prevalence of 18%, 
a design effect of 1.5 and 25% non-response, we 
needed to include a total of 1380 households. The 
municipality’s Planning Office provided the total 
population size of the Commune’s 11 neighbour-
hoods and a list of addresses. To select households, 
we subdivided all neighbourhoods into clusters of 15 
contiguous houses and randomly selected in each 
neighbourhood a number of clusters proportional to 
its size. For the present analysis we used data on 
general spending and OOPE for HTN from those 
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households that reported at least one hypertensive 
member aged 35 years or older.
Data collection
Interviews were carried out during home visits by 
professional interviewers who had been previously 
trained on the administration of the study question-
naire in order to guarantee reliability and consis-
tency. The head of the selected households 
responded to questions on basic spending. The first 
amongst the reported hypertensive family members 
aged 35 years or older that was encountered answered 
the questions on HTN-related expenses. If necessary, 
up to two repeated visits were made.
The questionnaire was designed to first provide 
general information on overall basic expenses, disag-
gregated by type. We enquired about food and trans-
port costs in the two weeks leading up to the 
interview. Spending on utilities, housing, health care 
in general, clothing, and education referred to the 
month before the interview. In the detailed questions 
on OOPE for HTN we inquired about both medical 
and non-medical costs. Questions related to expenses 
for pharmaceuticals referred to the month before the 
interview. For spending on consultations, laboratory 
tests and radiology the recall period was six months. 
For hospitalisations and emergencies, we collected 
cost data for the previous year. HTN associated direct 
non-medical costs for items such as transport to and 
food bought during journeys to HTN medical 
appointments were recorded with the recall period 
used for costs on the service utilised, as was expen-
diture for administrative procedures. Non- 
pharmacological treatment costs, including additional 
food expenditure due to HTN dietary requirements 
and expenses related to increased physical activity, 
such as visiting a fitness centre, were explored for 
the week before the interview.
Data analysis
Data were double entered in a Microsoft Excel 2010 
database and analysed using the Statistical Package 
for Social Sciences (SPSS) V.23 (SPSS Inc., Chicago, 
IL, USA). We developed checks for data entry with 
built-in filters and logic constraints.
We estimated annual basic households’ expendi-
ture and HTN-attributable OOPE, assuming a linear 
spending trend across the year. Colombian pesos 
were converted in US dollars adjusted at 2016 pur-
chasing power parity (USD-PPP). For socioeconomic 
stratification, we categorised households according to 
quintiles of the annual basic expenditure in the over-
all study population. Catastrophic health expenditure 
for HTN care was defined as HTN- attributable 
OOPE higher than 10% of the total annual basic 
household expenditure [31,32], or higher than 40% 
of the household non-food expenditure [18].
We used mean and standard deviation, and med-
ian and quartiles, to summarise the expenditure data 
for descriptive purposes. Unless otherwise reported, 
these measures were calculated for the studied sample 
as a whole, i.e. including units with no expenditure 
on a particular item. Bootstrapping was applied to 
estimate 95% Confidence Intervals (CI) for the 
means. The Kruskal-Wallis test was used to test for 
differences of OOPE among socioeconomic quintiles, 
the Mann-Whitney test for comparisons between the 
contributory and the subsidised insurance schemes, 
and the Fisher Exact Test for differences in percen-
tage of households with catastrophic expenditure 
across quintiles or between the contributory and sub-
sidised schemes.
Results
A total of 415 out of the 1380 sampled households 
had at least one member aged 35 years or older with 
a previous diagnosis of HTN; 67 and 8 of these 
families included one and two further hypertensive 
patients, respectively. We excluded three households 
with incomplete expenditure data and two with miss-
ing insurance information from the analysis. The 
average annual basic household expenditure was 
USD-PPP 12,255.59, 41.5% of which went to food 
(Table 1). Transport, utilities, and housing repre-
sented together 42.1% of the annual expenses, while 
health spending amounted to USD-PPP 757.16 or 
6.2%. We found high variability and a right-skewed 
distribution for all expenditure components, but their 
means and medians were generally comparable in 
both insurance schemes. The mean and median 
total expenditure was USD-PPP 12,979.92 and 
10,978.85 vs 11,535.90 and 9,296.87 for the 204 and 
206 households belonging to the contributory and 
subsidised scheme, respectively.
Table 2 summarises the annual basic household 
expenditure by item and socioeconomic quintile. 
The first, most deprived, to the fifth quintile con-
tained 64.6%, 53.7%, 42.7%, 40.2% and 50.0% of 
households from the subsidised scheme, respectively. 
Expenditure on all items displayed statistically signif-
icant differences (p < 0.001) between quintiles, with 
a monotonous increase from the first to the fifth one. 
Of note, spending on health care relative to total 
spending was highest in the most deprived quintile 
(8.3%) and lowest in the wealthiest one (4.8%).
Of the 410 hypertensive patients, 383 (93.4%) were 
under anti-hypertensive treatment. In Tables 3 and 4 
we detail their average annual OOPE for HTN care 
and its structure by insurance scheme and by socio-
economic quintile. 93.6% of patients in the contribu-
tory scheme but only 54.4% in the subsidised one 
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reported HTN-attributable OOPE for at least one 
item. The average OOPE was USD-PPP 193.13 (95% 
CI 151.97–234.29) in the former against 102.76 (95% 
CI 69.17–136.40) in the latter scheme, in which the 
average expenditure on each individual item was, in 
general, also lower. In both schemes, payments were 
mainly for direct non-medical expenses, 73.6% and 
82.4% of the total OOPE, respectively.
Overall, transport to attend health care appoint-
ments and non-pharmacological treatment -almost 
exclusively additional food expenditure due to HTN 
dietary requirements- were the critical drivers of 
direct non-medical expenses. Expenditure for trans-
port was frequent, but more often than not incurred 
by patients in the contributory scheme only, and it 
entailed a significantly higher average cost in that 
scheme than in the subsidised one. On the other 
hand, only about 5% of patients in either scheme 
informed OOPE for non-pharmacological treatment. 
Notwithstanding, due to the high cost per affiliate 
that incurred the expenditure, it made up almost 
a quarter and close to half of the average overall 
HTN-attributable OOPE in the contributory and the 
subsidised scheme, respectively. Direct medical 
expenses, in their turn, consisted mainly of payments 
for pharmacotherapy and were met three times more 
by affiliates of the contributory scheme. Of impor-
tance, OOPE for consultations, hospitalisations and 
emergency care was low and infrequent in both 
schemes.
Table 1. Annual basic household expenditure (USD-PPP) by item. Santa Cruz, Medellin-Colombia, 2016.
Item
Mean expenditure 
(95% CI) Standard deviation
Median 
(quartiles) % of mean total basic expenditure
Food 5,080.50 
(4,559.10–5,601.97)
5,371.25 3,769.31 
(2,317.78–6,502.78)
41.5
Transport 2,062.56 
(1,735.20–2,389.98)
3,372.29 1,316.05 
(407.24–2,477.27)
16.8
Utilities 1,607.18 
(1,518.97–1,695.39)
908.54 1,545.10 
(1,025.73–2,137.31)
13.1
Housing 1,495.34 
(1,340.23–1,650.40)
1,597.61 822.93 
(441.15–2,167.59)
12.2
Health 757.16 
(674.41–839.85)
852.13 662.73 
(0–1,021.47)
6.2
Clothing 743.80 
(446.24–1,041.37)
3,064.83 0 
(0–509.03)
6.1
Education 509.08 
(345.10–673.01)
1,688.74 0 
(0–322.39)
4.1
Total basic household expenditure 12,255.59 
(11,387.82–13,123.29)
8,938.19 10,328.39 
(6,915.11–14,928.04)
100.0
USD-PPP: US Dollars at Purchasing Power Parity; CI: Confidence Interval. 
Table 2. Annual basic household expenditure (USD-PPP) by socioeconomic quintile.Santa Cruz, Medellin-Colombia, 2016.
Item
Socioeconomic quintile (annual basic household expenditure)
Less than 6,335.82
From 6,335.82 to 
8,833.27
From 8,833.28 to 
11,726.87
From 11,726.88 to 
16,367.14 More than 16,367.14
Mean (median) expenditure 
Standard deviation 
(quartiles)
Food 1,904.86 (1,909.08) 
1,076.63 
(1,146.99–2,646.93)
2,848.34 (2,859.04) 
1,395.50 
(1,757.86 − 3,749.84)
4,020.75 (3,834.00) 
1,954.51 
(2,646.93–5,404.13)
5,883.09 (6,021.33) 
2,195.01 
(4,277.53–7,245.99)
10,745.59 (8,390.44) 
9,186.97 
(6,617.32–11,558.29)
Transport 534.66 (127.25) 
803.19 
(0.00–882.31)
1,263.65 (1,238.61) 
1,060.19 
(397.02–2,073.43)
1,927.41 (1,548.29) 
1,560.40 
(661.76–2,477.27)
2,028.55 (1,811.29) 
1,295.77 
(1,238.61–2,694.04)
4,558.60 (2,562.07) 
6,496.50 
(1,238.61–5,264.17)
Utilities 959.54 (1,051.81) 
572.58 
(610.81–1,354.89)
1,485.88 (1,511.78) 
826.71 
(906.75–1,968.13)
1,625.36 (1,538.28) 
857.81 
(1,028.22–2,219.35)
2,056.34 (1,898.10) 
922.76 
(1,516.92–2,667.32)
1,908.64 (1,870.89) 
912.92 
(1,272.57–2,453.53)
Housing 477.72 (407.24) 
518.01 
(152.73–551.43)
1,138.28 (661.76) 
1,142.67 
(441.15–1,323.46)
1,378.52 (882.31) 
1,315.84 
(441.15–1,879.98)
1,776.14 (1,018.06) 
1,666.08 
(661.76–3,054.17)
2,705.93 (2,646.93) 
2,012.97 
(882.31–3,826.15)
Health 362.19 (0.00) 
550.51 
(0.00–787.18)
470.85 (320.71) 
519.58 
(0.00–844.99)
677.88 (654.08) 
662.14 
(0.00–994.31)
1,072.47 (1,002.81) 
804.81 
(502.92–1,608.54)
1,202.27 (833.26) 
1,207.84 
(356.30–1,761.21)
Clothing 62.25 (0.00) 
267.06 
(0.00–0.00)
232.12 (0.00) 
580.04 
(0.00–0.00)
417.68 (0.00) 
815.79 
(0.00–509.03)
617.03 (0.00) 
889.23 
(0.00–1,018.06)
2,389.82 (393.67) 
6,477.95 
(0.00–2,036.12)
Education 43.05 (0.00) 
179.01 
(0.00–0.00)
102.81 (0.00) 
340.56 
(0.00–0.00)
205.95 (0.00) 
399.73 
(0.00–186.64)
579.17 (0.00) 
1,055.48 
(0.00–756.73)
1,614.32 (635.42) 
3,355.04 
(0.00–2,358.50)
Total basic household 
expenditure
4,344.27 (4,583.32) 
1,397.29 
(3,443.57–5,440.64)
7,541.98 (7,566.64) 
722.87 
(6,915.11–8,155.28)
10,253.60 (10,328.39) 
822.06 
(9,597.24–10,918.60)
14,012.80 (14,234.54) 
1,309.19 
(12,897.88–14,928.04)
25,125.18 (20,621.47) 
11,740.07 
(17,960.10–26,277.85)
USD-PPP: US Dollars at Purchasing Power Parity. 
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Regardless of expenditure item, OOPE within 
socioeconomic quintiles was, as a rule, significantly 
higher for patients from the contributory scheme 
(Table 4). Within each insurance scheme, the differ-
ences across the socioeconomic quintiles were usually 
rather minor and they rarely showed a clear trend. 
Nevertheless, in the contributory scheme, patients in 
the two better off quintiles had significantly higher 
expenditure for medical consultations compared to 
the other strata, and in the subsidised scheme OOPE 
for pharmacotherapy and non-pharmacological treat-
ment tended to be mainly incurred in the fifth 
quintile.
We also explored the impact of OOPE for HTN on 
the household budget (Table 5). The attributable 
OOPE per hypertensive family member represented 
on average 1.6% of the total annual basic household 
expenditure. This proportion was significantly higher 
in the contributory than in the subsidised scheme, 
both overall and within each socioeconomic quintile. 
Furthermore, within each insurance scheme, the 
OOPE as percentage of basic expenditure was differ-
ent between quintiles and, for both schemes con-
founded, significantly higher for the most deprived 
ones, attaining 2.3% in the bottom quintile compared 
to 1.1% in the fifth quintile. OOPE for HTN as 
percentage of the households’ non-food expenditure 
showed the same pattern. Overall, it attained 2.9%, 
with a gradient over quintiles and higher percentages 
in the contributory scheme.
Eight households in total (2.0%; 95% CI 1.0%- 
3.8%) had OOPE for one hypertensive family mem-
ber surpassing 10% of their annual basic expenditure, 
of which six belonged to the two bottom quintiles. At 
the above threshold, catastrophic spending for HTN 
was more frequent, but not significantly so, among 
households enlisted in the subsidised scheme. The 
four households with catastrophic expenditure that 
belonged to the bottom socioeconomic quintile had, 
for the family as a whole, a basic expenditure below 
60% of one minimum salary. The main drivers of 
catastrophic expenditure for the in total six families 
from the subsidised scheme were food prescribed as 
dietary requirement for non-pharmacological treat-
ment (4), transport for HTN consultations (2) and 
anti-hypertensive drugs (1). For the two households 
affiliated to the contributory scheme, catastrophic 
OOPE was mainly due to expenditure for both non- 
pharmacological treatment and anti-hypertensive 
medication.
Discussion
OOPE for HTN care was reported by 93.6% and 
54.4% of the hypertensive patients and amounted, 
on average, to USD-PPP 193.13 and 102.76 per year 
for the insured in the contributory and subsidised 
schemes, respectively. Non-medical OOPE repre-
sented 73.6% of the total OOPE in the contributory 
and 82.4% in the subsidised scheme and was mainly 
made up by expenses for transport to HTN appoint-
ments and for non-pharmacological treatment, essen-
tially food related to HTN dietary requirements. The 
former cost was particularly frequent in the contrib-
utory scheme, the latter infrequent in both schemes. 
Medical OOPE was higher on average in the contrib-
utory scheme and experienced some three times more 
frequently than in the subsidised one. It was, in both 
schemes, mostly brought on by pharmacological 
treatment, while remarkably low for consultations, 
hospitalisations and emergency care. HTN- 
attributable OOPE for a hypertensive patient repre-
sented on average 1.6% of the total annual basic 
household expenses and 2.9% of the non-food 
Table 3. Patient’s annual OOPE for HTN care (USD-PPP) by insurance scheme. Santa Cruz, Medellín-Colombia, 2016.
Number and % of 
HTN patients with OOPE
Mean OOPE of HTN 
patients 
with expenditure 
on the item
Mean OOPE 
of all HTN patients
% of the total OOPE of 
all HTN patients
Contributory* Subsidised* Contributory Subsidised Contributory Subsidised Contributory Subsidised
Direct medical expenses
Pharmacotherapy 125 61.3 43 20.9 53.54 67.66 32.83 14.12 17.0 13.7
Scheduled consultations 89 43.6 9 4.4 14.98 6.65 6.54 0.27 3.4 0.3
Hospitalisations 2 1.0 4 1.9 259.60 160.36 2.54 3.14 1.3 3.1
Laboratory tests 63 30.9 10 4.9 10.92 8.17 3.35 0.38 1.7 0.4
Spontaneous consultations 11 5.4 2 1.0 41.43 6.87 2.22 0.05 1.1 0.1
Radiology 28 13.7 3 1.5 10.28 9.19 1.41 0.11 0.7 0.1
Emergency care 6 2.9 0 0.0 67.60 0.00 2.00 0.00 1.0 0.0
Sub-total medical expenses 149 73.0 49 23.8 69.71 76.20 50.89 18.12 26.4 17.6
Direct non-medical expenses
Transport related to HTN consultations 173 84.8 73 35.4 93.78 86.80 79.50 30.77 41.2 29.9
Food bought during HTN consultations 40 19.6 25 12.1 77.56 44.46 15.20 5.41 7.9 5.3
Non-pharmacological treatment 9 4.4 12 5.8 1,039.15 830.82 45.86 48.40 23.7 47.1
Administrative procedures related to 
HTN consultations
2 1.0 1 0.5 169.71 20.34 1.68 0.11 0.9 0.1
Sub-total non-medical expenses 173 84.8 87 42.2 167.71 200.43 142.24 84.64 73.6 82.4
TOTAL 191 93.6 112 54.4 206.27 189.02 193.13 102.76 100.0 100.0
OOPE: out-of-pocket expenditure; HTN: hypertension/hypertensive; USD-PPP: US Dollars at Purchasing Power Parity. 
*Out of 204 and 206 HTN patients insured in the contributory and subsidised scheme, respectively. 
GLOBAL HEALTH ACTION 5
Ta
bl
e 
4.
 P
at
ie
nt
s’ 
O
O
PE
 f
or
 H
TN
 c
ar
e 
(U
SD
-P
PP
) 
by
 in
su
ra
nc
e 
sc
he
m
es
 a
nd
 s
oc
io
ec
on
om
ic
 q
ui
nt
ile
. S
an
ta
 C
ru
z,
 M
ed
el
lin
-C
ol
om
bi
a,
 2
01
6.
Ite
m
In
su
ra
nc
e 
sc
he
m
e 
n 
(%
) 
of
 H
TN
 p
at
ie
nt
s 
w
ith
 O
O
PE
H
ou
se
ho
ld
 s
oc
io
ec
on
om
ic
 q
ui
nt
ile
 (
an
nu
al
 h
ou
se
ho
ld
 e
xp
en
di
tu
re
)
Al
l 
(9
5%
 C
I)
Le
ss
 t
ha
n 
6,
33
5.
82
Fr
om
 6
,3
35
.8
2 
to
 8
,8
33
.2
7
Fr
om
 8
,8
33
.2
8 
to
 1
1,
72
6.
87
Fr
om
 1
1,
72
6.
88
 t
o 
16
,3
67
.1
4
M
or
e 
th
an
 1
6,
36
7.
14
p-
va
lu
e*
M
ea
n 
O
O
PE
 p
er
 p
at
ie
nt
D
ire
ct
 m
ed
ic
al
 e
xp
en
se
s
Ph
ar
m
ac
ot
he
ra
py
Co
nt
rib
ut
or
y 
12
5 
(6
1.
3)
32
.8
0 
(2
2.
71
–4
2.
94
)
22
.4
4
29
.9
1
31
.6
9
51
.1
1
22
.2
3
0.
02
8
Su
bs
id
is
ed
 4
3 
(2
0.
9)
14
.1
2 
(8
.2
2–
20
.0
1)
7.
90
8.
49
13
.9
0
8.
38
32
.9
4
0.
02
6
D
iff
er
en
ce
 (
p-
va
lu
e*
*)
18
.6
8 
(<
0.
00
1)
14
.5
0 
(<
0.
00
1)
21
.4
2 
(<
0.
00
1)
17
.7
9 
(0
.0
56
)
42
.7
3 
(<
0.
00
1)
−
10
.7
1 
(0
.4
49
)
-
Sc
he
du
le
d 
co
ns
ul
ta
tio
ns
Co
nt
rib
ut
or
y 
89
 (
43
.6
)
6.
54
 (
1.
51
–1
1.
57
)
4.
06
4.
54
3.
03
6.
11
14
.7
1
0.
04
1
Su
bs
id
is
ed
 9
 (
4.
4)
0.
27
 (
0.
11
–0
.4
9)
0.
11
0.
11
1.
03
0.
16
0.
22
0.
21
4
D
iff
er
en
ce
 (
p-
va
lu
e)
6.
27
 (
<
0.
00
1)
3.
95
 (
<
0.
00
1)
4.
43
 (
<
0.
00
1)
2.
00
 (
0.
04
3)
5.
95
 (
<
0.
00
1)
14
.4
9 
(0
.0
01
)
-
La
bo
ra
to
ry
 t
es
ts
Co
nt
rib
ut
or
y 
63
 (
30
.9
)
3.
35
 (
1.
95
–4
.8
1)
1.
57
4.
38
2.
87
4.
33
3.
19
0.
13
2
Su
bs
id
is
ed
 1
0 
(4
.9
)
0.
38
 (
0.
11
–0
.6
5)
0.
22
0.
11
0.
97
0.
16
0.
65
0.
22
0
D
iff
er
en
ce
 (
p-
va
lu
e)
2.
97
 (
<
0.
00
1)
1.
35
 (
0.
00
1)
4.
27
 (
<
0.
00
1)
1.
90
 (
0.
21
1)
4.
17
 (
0.
00
4)
2.
54
 (
0.
01
1)
-
Ra
di
ol
og
y
Co
nt
rib
ut
or
y 
28
 (
13
.7
)
1.
41
 (
1.
95
–4
.8
1)
0.
49
0.
54
1.
68
2.
97
0.
76
0.
73
4
Su
bs
id
is
ed
 3
 (
1.
5)
0.
11
 (
0.
11
–0
.5
6)
0.
00
0.
11
0.
65
0.
00
0.
00
0.
16
5
D
iff
er
en
ce
 (
p-
va
lu
e)
1.
30
 (
<
0.
00
1)
0.
49
 (
0.
01
8)
0.
43
 (
0.
12
7)
1.
03
 (
0.
09
0)
2.
97
 (
0.
03
8)
0.
76
 (
0.
01
2)
-
Sp
on
ta
ne
ou
s 
co
ns
ul
ta
tio
ns
Co
nt
rib
ut
or
y 
11
 (
5.
4)
2.
22
 (
0.
00
–5
.4
1)
0.
00
0.
49
0.
27
6.
76
2.
22
0.
46
7
Su
bs
id
is
ed
 2
 (
1.
0)
0.
05
 (
0.
00
–0
.1
6)
0.
00
0.
00
0.
38
0.
00
0.
00
0.
04
4
D
iff
er
en
ce
 (
p-
va
lu
e)
2.
17
 (
0.
01
1)
-
0.
49
 (
0.
05
9)
−
0.
11
 (
0.
91
9)
6.
76
 (
0.
09
5)
2.
22
 (
0.
31
7)
-
H
os
pi
ta
lis
at
io
ns
Co
nt
rib
ut
or
y 
2 
(1
.0
)
2.
54
 (
0.
00
–6
.3
3)
0.
00
0.
00
0.
00
7.
19
4.
06
0.
63
1
Su
bs
id
is
ed
 4
 (
1.
9)
3.
14
 (
0.
00
–8
.8
1)
0.
00
0.
76
0.
38
0.
00
14
.4
9
0.
36
6
D
iff
er
en
ce
 (
p-
va
lu
e)
−
0.
60
 (
0.
42
3)
-
−
 0
.7
6 
(0
.3
53
)
−
 0
.3
8 
(0
.0
99
)
7.
19
 (
0.
41
2)
−
10
.4
3 
(0
.9
86
)
-
Em
er
ge
nc
y 
ca
re
Co
nt
rib
ut
or
y 
6 
(2
.9
)
2.
00
 (
0.
00
–5
.4
1)
0.
59
0.
43
0.
00
7.
57
0.
00
0.
20
5
Su
bs
id
is
ed
 0
 (
0.
0)
0.
00
 (
0.
00
–0
.0
0)
0.
00
0.
00
0.
00
0.
00
0.
00
-
D
iff
er
en
ce
 (
p-
va
lu
e)
2.
00
 (
0.
01
3)
0.
59
 (
0.
05
4)
0.
43
 (
0.
28
2)
-
7.
57
 (
0.
15
0)
-
-
Su
b-
to
ta
l d
ire
ct
 m
ed
ic
al
 
ex
pe
ns
es
Co
nt
rib
ut
or
y 
14
9 
(7
3.
0)
50
.8
9 
(3
5.
21
–6
6.
63
)
29
.1
5
40
.2
9
39
.4
8
86
.1
0
47
.2
1
0.
02
4
Su
bs
id
is
ed
 4
9 
(2
3.
8)
18
.1
2 
(9
.9
5–
26
.2
8)
8.
22
9.
57
17
.3
6
8.
65
48
.3
0
0.
00
4
D
iff
er
en
ce
 (
p-
va
lu
e)
32
.7
7 
(<
0.
00
1)
20
.9
3 
(<
0.
00
1)
30
.7
2 
<
 0
.0
01
)
22
.1
2 
(0
.0
03
)
77
.4
5 
(<
0.
00
1)
−
1.
09
 (
0.
14
4)
-
D
ire
ct
 n
on
-m
ed
ic
al
 e
xp
en
se
s
Tr
an
sp
or
t 
re
la
te
d 
to
 H
TN
 
co
ns
ul
ta
tio
ns
Co
nt
rib
ut
or
y 
17
3 
(8
4.
8)
79
.5
0 
(6
5.
71
–9
3.
29
)
76
.3
1
88
.9
7
61
.2
2
82
.2
6
90
.5
9
0.
55
1
Su
bs
id
is
ed
 7
3 
(3
5.
4)
30
.7
7 
(2
0.
77
–4
0.
72
)
20
.5
0
31
.4
8
56
.3
0
26
.5
5
24
.8
2
0.
23
9
D
iff
er
en
ce
 (
p-
va
lu
e)
48
.7
3 
(<
0.
00
1)
55
.8
1 
(<
0.
00
1)
57
.4
9 
(<
0.
00
1)
4.
92
 (
0.
02
1)
55
.7
1 
(<
0.
00
1)
65
.7
7 
(<
0.
00
1)
-
N
on
-p
ha
rm
ac
ol
og
ic
al
 
tr
ea
tm
en
t
Co
nt
rib
ut
or
y 
9 
(4
.4
)
45
.8
6 
(1
3.
47
–7
8.
20
)
0.
00
0.
00
58
.1
9
81
.0
2
64
.5
8
0.
27
7
Su
bs
id
is
ed
 1
2 
(5
.8
)
48
.4
0 
(1
7.
36
–7
9.
45
)
26
.6
1
55
.1
6
18
.9
3
16
.0
6
12
0.
50
0.
65
1
D
iff
er
en
ce
 (
p-
va
lu
e)
−
2.
54
 (
0.
54
2)
−
26
.6
1 
(0
.1
95
)
−
55
.1
6 
(0
.1
03
)
39
.2
6 
(0
.4
59
)
64
.9
6 
(0
.3
21
)
−
55
.9
2 
(0
.4
11
)
-
Fo
od
 b
ou
gh
t 
du
rin
g 
H
TN
 
co
ns
ul
ta
tio
n
Co
nt
rib
ut
or
y 
40
 (
19
.6
)
15
.2
0 
(9
.4
6–
20
.9
3)
5.
90
24
.6
6
7.
36
17
.6
3
19
.2
0
0.
45
9
Su
bs
id
is
ed
 2
5 
(1
2.
1)
5.
41
 (
2.
59
–8
.2
2)
3.
03
4.
65
8.
38
4.
33
7.
63
0.
60
5
D
iff
er
en
ce
 (
p-
va
lu
e)
9.
79
 (
0.
02
3)
2.
87
 (
0.
69
6)
20
.0
1 
(0
.7
30
)
−
1.
02
 (
0.
30
7)
13
.3
0 
(0
.0
90
)
11
.5
7 
(0
.3
36
)
-
Ad
m
in
is
tr
at
iv
e 
pr
oc
ed
ur
es
 
re
la
te
d 
to
 H
TN
 
ap
po
in
tm
en
ts
Co
nt
rib
ut
or
y 
2 
(1
.0
)
1.
68
 (
0.
00
–4
.0
0)
7.
03
0.
00
0.
00
0.
00
3.
30
0.
40
1
Su
bs
id
is
ed
 1
 (
0.
5)
0.
11
 (
0.
00
–0
.2
7)
0.
00
0.
00
0.
59
0.
00
0.
00
0.
29
9
D
iff
er
en
ce
 (
p-
va
lu
e)
1.
57
 (
0.
55
3)
7.
03
 (
0.
17
6)
-
−
0.
59
 (
0.
24
7)
-
3.
30
 (
0.
31
7)
-
Su
b-
to
ta
l d
ire
ct
 n
on
-m
ed
ic
al
 
ex
pe
ns
es
Co
nt
rib
ut
or
y 
17
3 
(8
4.
8)
14
2.
24
 (
10
6.
92
–1
77
.5
5)
89
.1
8
11
3.
63
12
6.
77
18
0.
91
17
7.
66
0.
74
7
Su
bs
id
is
ed
 8
7 
(4
2.
2)
84
.6
4 
(5
1.
59
–1
17
.6
8)
50
.1
3
91
.2
4
84
.1
5
46
.8
9
15
2.
95
0.
50
6
D
iff
er
en
ce
 (
p-
va
lu
e)
57
.6
0 
(<
0.
00
1)
39
.0
5 
(<
0.
00
1)
22
.3
9 
(0
.0
01
)
42
.6
2 
(0
.0
24
)
13
4.
02
 (
<
0.
00
1)
24
.7
1 
(0
.0
01
)
-
To
ta
l d
ire
ct
 m
ed
ic
al
 a
nd
 n
on
- 
m
ed
ic
al
 e
xp
en
se
s
Co
nt
rib
ut
or
y 
19
1 
(9
3.
6)
19
3.
13
 (
15
1.
97
–2
34
.2
9)
11
8.
39
15
3.
92
16
6.
25
26
7.
01
22
4.
88
0.
12
4
Su
bs
id
is
ed
 1
12
 (
54
.4
)
10
2.
76
 (
69
.1
7–
13
6.
40
)
58
.4
1
10
0.
86
10
1.
57
55
.5
4
20
1.
24
0.
03
8
D
iff
er
en
ce
 (
p-
va
lu
e)
90
.3
7 
(<
0.
00
1)
59
.9
8 
(<
0.
00
1)
53
.0
6 
(<
0.
00
1)
64
.6
8 
(0
.0
10
)
21
1.
47
 (
<
0.
00
1)
23
.6
4 
(0
.0
22
)
-
O
O
PE
: o
ut
-o
f-
po
ck
et
 e
xp
en
di
tu
re
; H
TN
: h
yp
er
te
ns
io
n;
 U
SD
-P
PP
: U
S 
D
ol
la
rs
 a
t 
Pu
rc
ha
si
ng
 P
ow
er
 P
ar
ity
; C
I: 
Co
nf
id
en
ce
 In
te
rv
al
. 
*K
ru
sk
al
-W
al
lis
 t
es
t 
fo
r 
di
ffe
re
nc
es
 a
cr
os
s 
so
ci
oe
co
no
m
ic
 q
ui
nt
ile
s.
 
**
M
an
n–
W
hi
tn
ey
 U
 t
es
t 
fo
r 
di
ffe
re
nc
es
 b
et
w
ee
n 
Co
nt
rib
ut
or
y 
an
d 
Su
bs
id
is
ed
 s
ch
em
es
. 
6 E. LONDOÑO AGUDELO ET AL.
expenditure. These proportions were higher for the 
bottom socioeconomic quintiles and within quintiles 
higher in the contributory scheme. In two percent of 
households it led to catastrophic health expenditure 
due to the HTN care. The risk was higher, but not 
significantly so, among households in the subsidised 
scheme and overall three quarters of the affected 
belonged to the most deprived quintiles. Financial 
costs related to HTN dietary requirements stood out 
as the critical determinant, followed by payments for 
anti-hypertensive medication and transport for HTN 
consultations.
Our study’s main limitation is having been con-
ducted in a low-income urban setting. Almost half of 
the Colombian population lives in comparable envir-
onments, but our results may not reflect the situation 
in upper-class urban zones or in underserved rural 
areas. The use of a questionnaire for measuring 
expenditure also entails potential drawbacks, related 
to respondents’ willingness to disclose financial infor-
mation and ability to correctly recall actual expenses. 
The latter was mitigated by choosing variable recall 
periods, adapted to the nature of the different exam-
ined expenditure items. Finally, selecting just one 
household member with HTN to collect data on 
OOPE on, will have resulted in somewhat underrat-
ing the proportion of families in which this condition 
leads to catastrophic expenditure. However, our esti-
mates of OOPE in itself and of its effect on household 
budgets for one hypertensive patient are unbiased.
Making use of information on household expen-
diture instead of income is an asset to our study. It 
better reflects the longer-term financial state of 
affairs, particularly in resource-constrained settings 
[33–36]. The study’s major strength is providing yet 
unavailable population-based evidence on the magni-
tude of OOPE for HTN care in Colombia, on its 
impact on household budgets and on HTN- 
attributable catastrophic health expenditure. Our 
findings could guide policymakers in strengthening 
financial protection and ensuring equitable access to 
care for families belonging to deprived socioeco-
nomic population segments.
The basic household expenses we document are 
compatible with Santa Cruz Commune’s household 
income reported by Medellin’s government [37]. 
Moreover, food expenditure making up the highest 
share for the lowest quintile, followed by housing and 
transport, is in line with the patterns observed in 
Cauca, Colombia [38] and with regional findings 
[39]. This confers face value to our data. Also, it is 
a finding of note that over 40% of the households 
belonging to the first and second socioeconomic 
quintiles are insured under the contributory scheme, 
but it is not surprising given the Commune’s low- 
income profile and many of its formally employed, 
which are therefore affiliated to that scheme, earning 
meagre salaries.
The -in absolute terms- fairly low OOPE for HTN 
found in this study is in line with Colombia’s overall 
OOPE for health that represents a moderate 16% of 
the country’s total health expenditure [19]. 
Nevertheless, low OOPE is not always an indication 
of equitable access since it may be due to lack of 
utilization of health services [20]. In Colombia, 
despite 96% health insurance coverage [40], almost 
a third of the population reports financial barriers to 
access care [19]. A 2015 report further indicates that 
Table 5. Summary indicators of OOPE for HTN care. Santa Cruz, Medellin-Colombia, 2016.
Summary indicator
Insurance 
scheme
Socioeconomic quintile (annual household expenditure, USD-PPP)
All 
households
Less than 
6,335.82
From 6,335.82 
to 8,833.27
From 8,833.28 
to 11,726.87
From 11,726.88 
to 16,367.14
More than 
16,367.14
p- value 
(* or ***)
OOPE per HTN patient as % of household expenditure
OOPE for HTN care as % of basic 
household expenditure
All 1.55 2.27 1.69 1.40 1.31 1.08 0.287
Contributory 1.83 2.53 2.01 1.70 1.93 1.18 <0.001
Subsidised 1.27 2.12 1.40 0.99 0.38 0.98 0.289
p-value** <0.001 <0.001 <0.001 0.008 <0.001 0.032 -
OOPE for HTN care as % of non- 
food household expenditure
All 2.88 3.45 3.26 2.95 2.66 2.02 0.398
Contributory 3.33 3.96 3.29 3.35 3.98 2.14 0.001
Subsidised 2.40 3.17 3.23 2.41 0.69 1.91 0.323
p-value** <0.001 <0.001 0.001 0.004 <0.001 0.011 -
Number (%) of households with catastrophic expenditure due to OOPE for one HTN patient
OOPE for HTN care over 10% of 
basic household expenditure
All 8 (2.0) 4 (4.9) 2 (2.4) 2 (2.4) 0 (0.0) 0 (0.0) 0.091
Contributory 2 (1.0) 0 (0.0) 0 (0.0) 2 (4.3) 0 (0.0) 0 (0.0) 0.145
Subsidised 6 (2.9) 4 (7.5) 2 (4.5) 0 (0.0) 0 (0.0) 0 (0.0) 0.118
p-value*** 0.284 0.292 0.497 0.505 - -
OOPE for HTN care over 40% of 
non-food household 
expenditure
All 2 (0.5) 1 (1.2) 1 (1.2) 0 (0.0) 0 (0.0) 0 (0.0) 0.198
Contributory 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) -
Subsidised 2 (1.0) 1 (1.9) 1 (2.3) 0 (0.0) 0 (0.0) 0 (0.0) 0.741
p-value*** 0.499 1.000 1.000 - - -
OOPE: out-of-pocket expenditure; HTN: hypertension/hypertensive; USD-PPP: US Dollars at Purchasing Power Parity. 
* Kruskal-Wallis Test for differences in OOPE for HTN across socioeconomic quintiles. 
**Mann–Whitney U test for differences in OOPE for HTN between contributory and subsidised schemes. 
*** Fisher Exact Test for differences in % of households with catastrophic expenditure between contributory and subsidised schemes or across quintile. 
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the households in the lowest socioeconomic quintile 
had the highest OOPE for health [41], which is in line 
with the findings of a literature review on the global 
situation in LMICs [42].
In the present study the magnitude of OOPE per 
patient for HTN was lower in the bottom socioeco-
nomic quintile, where it accounted for 2.3% of the 
total basic household spending, than in the other 
ones. It led to catastrophic expenditure in 4.9% of 
households in the former quintile, in contrast to 1.2% 
in the better off segment of the population. Both 
figures may seem negligible in comparison with 
a staggering 23% catastrophic expenditure attributa-
ble to HTN in households with a hypertensive mem-
ber in the rural areas of Shaanxi Province, China [43], 
but WHO sets the threshold for good performance 
with regard to financial protection in the Latin 
America and the Caribbean region at 2% catastrophic 
overall health expenditure [19]. Precisely equal to 
the – from that perspective quite alarming- 2.0% 
found in our study for just one particular disorder 
in one household member. Furthermore, HTN is 
a very prevalent condition in Colombia [12] and 
a common reason for outpatient care that has been 
exempted from user fees and co-payments.
The health system has succeeded in reducing to 
a minimum the OOPE for consultations, hospitalisa-
tions and emergency care for hypertensive patients 
and seems to protect from catastrophic expenditure 
due to major health shocks. However, particularly for 
patients enrolled in the contributory scheme, trans-
port expenses related to attending HTN care appoint-
ments and, to a lesser extent, payments for 
pharmaceuticals generate non negligible OOPE. The 
former reveals the fragmentation of the Colombian 
health system and its disintegrated care provision. 
Health insurance companies of the contributory 
scheme tend to vertically integrate their facilities fol-
lowing profit maximising efficiency criteria rather 
than accommodating for the territorial distribution 
of users.
While around half of the more than 110,000 Santa 
Cruz dwellers are enlisted in the contributory 
scheme, they avail of no facilities providing health 
services in the Commune. Moreover, contributory 
insurance companies do not contract the provision 
of primary health care to the public health facilities 
operating in the area. In order to be attended, be it 
just for blood pressure control, contributory scheme 
affiliates are forced to travel downtown or to the 
South/South-west communes of the city, where 
most of the scheme’s health care facilities are located. 
Besides creating geographical barriers to care, it sub-
stantially contributes to patients insured in this 
scheme having overall higher OOPE for HTN than 
to those enlisted in the subsidised one. The OOPE for 
anti-hypertensive medication in the contributory 
scheme also finds its main origin in the geographi-
cally remote location of the insurers’ care facilities 
and the pharmacies linked to them [44]. It gives rise 
to patients acquiring drugs in nearby home private 
outlets – a problem compounded, in both schemes, 
by occasional stock-outs. It has been argued that 
insurer-based vertical integration does not generate 
distortions in the larger Colombian cities [45], but 
our findings suggest that ‘a market-driven vertical 
integration between health care insurers and provi-
ders, based on cost-containment mechanisms’ [46], is 
affecting not only the provision of care but also access 
and financial protection.
A final finding of importance is that in spite of 
a small proportion of patients incurring expenses related 
to HTN dietary requirements, the amount spent by the 
ones that do so is high on average and a main driver of 
catastrophic health expenditure, in particular in the 
lowest socioeconomic quintile. This is in line with evi-
dence that healthier dietary patterns entail cost about 
1.50 USD per person a day higher than the least healthy 
ones [47] and that food insecurity primarily affects 
people living on stagnant wages in poor urban commu-
nities [48,49]. Our findings highlight the vulnerability of 
the most deprived urban households, for whom even 
modest expenses to comply with medical dietary pre-
scriptions can lead to financial hardship.
Conclusions
OOPE for HTN care is moderate but frequent in this 
Colombian low-income urban community and for 
the larger part made up of direct non-medical 
expenses. Catastrophic health expenditure for HTN 
is infrequent, but affects some 5.0% of households in 
the bottom socioeconomic quintile. Our findings 
point to the financial vulnerability of these house-
holds. They also highlight the fragmented and disin-
tegrated nature of the Colombian health care system. 
While this suggests a need for more fundamental 
structural reforms we can, strictly based on our 
results, recommend implementing a public policy 
measure aimed at strengthening financial protection: 
cover, for the most deprived households, the costs of 
chronic disease related dietary requirements and of 
transport for attending health services. Furthermore, 
decentralising the contributory insurance scheme’s 
primary care facilities should reduce, in itself, overall 
out-of-pocket expenditure in affiliated members.
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